Reacción #1135886

ord-6307960c13544c79ba0128554483b877

Ecuación de reacción

[Cl-].[Na+]
NaCl
CNCC(=O)OC.Cl
sarcosine methylester hydrochloride
CCN(CC)CC
triethylamine
ClCc1cn2ccccc2n1
2-(chloromethyl)imidazo[1,2-a]pyridine
COC(=O)CN(C)Cc1cn2ccccc2n1
methyl 2-((imidazo[1,2-a]pyridin-2-ylmethyl)(methyl)amino)acetate
Rendimiento 26.0%

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.STIRRINGThe mixture was stirred at r.t. for 16 h
  2. 2
    ConcentraciónThe aqueous phase was concentrated in vacuo
  3. 3
    OtroThe residue was triturated in 75 ml of isopropanol
  4. 4
    Otrothe salts were removed by filtration
  5. 5
    Concentraciónthe filtrate was concentrated in vacuo
  6. 6
    OtroThe crude residue was purified by flash chromatography on a silica gel cartridge (eluent

Procedimiento

0.303 g (1.773 mmol) of 2-(chloromethyl)imidazo[1,2-a]pyridine were dissolved in 15 ml of dimethylformamide with magnetic stirring and then 0.253 g (1.773 mmol) of sarcosine methylester hydrochloride and 0.741 ml (5.32 mmol) of triethylamine were added. The mixture was stirred at r.t. for 16 h, and then treated with 30 ml of a saturated NaCl aqueous solution. The aqueous phase was concentrated in vacuo. The residue was triturated in 75 ml of isopropanol, the salts were removed by filtration and the filtrate was concentrated in vacuo. The crude residue was purified by flash chromatography on a silica gel cartridge (eluent: dichloromethane/methanol, 95/5, v/v). 0.107 g (yield=26%) of methyl 2-((imidazo[1,2-a]pyridin-2-ylmethyl)(methyl)amino)acetate were obtained as a pale yellow oil. LC-MS: m/z=234 (MH+); UV purity at 254 nm=99%. 1H NMR (300 MHz, DMSO) δ 8.49 (d, J=6.8 Hz, 1H), 7.79 (s, 1H), 7.47 (d, J=9.0 Hz, 1H), 7.18 (ddd, J=9.0, 6.7, 1.2 Hz, 1H), 6.84 (td, J=6.7, 1.1 Hz, 1H), 3.76 (s, 2H), 3.61 (s, 3H), 2.32 (s, 3H).

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09381191B2uspto-grants-2016_07